These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4611056)

  • 1. Pyelonephritis XV. Long-term study of ascending Escherichia coli pyelonephritis in mice.
    Kalmanson GM; Montgomerie JZ; Hubert EG; Barajas L; Guze LB
    Yale J Biol Med; 1973 Jun; 46(3):196-202. PubMed ID: 4611056
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of certain immunological mechanism in experimental pyelonephritis in rabbits. II. Bacterio-immunological studies].
    Gelber J; Sliwińska H; Rydzewska E; Pozorska D
    Pediatr Pol; 1970 Jan; 45(1):21-31. PubMed ID: 4905194
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyelonephritis XVI. correlates of parasite virulence in acute ascending Escherichia coli pyelonephritis in mice undergoing diuresis.
    Guze LB; Montgomerie JZ; Potter CS; Kalmanson GM
    Yale J Biol Med; 1973 Jun; 46(3):203-11. PubMed ID: 4611057
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive treatment of experimental pyelonephritis with a combination of oxytetracycline and azathioprine.
    Hagemann I; Philipp H; Briedigkeit H; Dutz H
    Clin Nephrol; 1973; 1(6):372-6. PubMed ID: 4594998
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.
    Rice JC; Peng T; Spence JS; Wang HQ; Goldblum RM; Corthésy B; Nowicki BJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3583-91. PubMed ID: 16236807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of passive hemagglutination reaction in the diagnosis of pyelonephritis].
    Wańkowicz Z
    Pol Tyg Lek; 1975 Dec; 30(48):2017-9. PubMed ID: 1105477
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of active immunisation on ascending pyelonephritis in the rat.
    Radford NJ; Chick S; Ling R; Coles GA; Asscher AW
    J Pathol; 1974 Mar; 112(3):169-75. PubMed ID: 4601025
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of antibody in experimental pyelonephritis.
    Kyriakos M; Ikari NS
    J Pathol; 1969 Mar; 97(3):513-25. PubMed ID: 4900932
    [No Abstract]   [Full Text] [Related]  

  • 10. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.
    Kaboré AF; Simard M; Bergeron MG
    J Infect Dis; 1999 May; 179(5):1162-72. PubMed ID: 10191219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staphylococcal infection as a predisposing factor in experimental colipyelonephritis].
    Breunung M; Breunung MM; Peschel HG
    Padiatr Padol; 1971 Mar; 6(1):58-74. PubMed ID: 4949645
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunofluorescent localization of bacterial antigen in pyelonephritis. I. The use of antisera against the common enterobacterial antigen in experimental renal lesions.
    Aoki S; Merkel M; Aoki M; McCabe WR
    J Lab Clin Med; 1967 Aug; 70(2):204-12. PubMed ID: 5339482
    [No Abstract]   [Full Text] [Related]  

  • 13. [Susceptibility of the solitary, hypertrophied kidney following unilateral nephrectomy to the so-called ascending Coli pyelonephritis in the white rat].
    Tra LN; Seipelt H; Grossmann P; Hilgenfeld E; Hagemann I; Ditscherlein G
    Z Urol Nephrol; 1975 Mar; 68(3):205-12. PubMed ID: 775850
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.
    Kaijser B; Olling S
    J Infect Dis; 1973 Jul; 128(1):41-9. PubMed ID: 4577974
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection against experimental pyelonephritis by antibodies to pili.
    Silverblatt FJ; Weinstein R; Rene P
    Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and urinary immune response in experimental E. coli pyelonephritis of mice.
    Bluestone R; Goldberg LS; Kalmanson GM; Guze LB
    Int Arch Allergy Appl Immunol; 1973; 45(4):571-81. PubMed ID: 4200918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
    Falkenhagen U; Handschuck I; Nimmich W; Zingler G; Naumann G
    Z Urol Nephrol; 1984 Nov; 77(11):629-38. PubMed ID: 6395557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice.
    Gupta R; Ganguly NK; Ahuja V; Joshi K; Sharma S
    J Med Microbiol; 1995 Jul; 43(1):33-6. PubMed ID: 7608952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of water and furosemide-induced diuresis on the acquisition and course of experimental pyelonephritis.
    D'Alessio DJ; Jackson GG; Olexy VM; Gantt CL
    J Lab Clin Med; 1971 Jul; 78(1):130-7. PubMed ID: 5569243
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic pyelonephritis: modulation of host defenses by cyclosporin A.
    Findon G; Miller TE
    J Lab Clin Med; 1989 Aug; 114(2):157-64. PubMed ID: 2666534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.